Product References — Human Plasma

Single Donor Human Plasma (Blood Derived) from Innovative Research was used in the following study:   LC-MS/MS Method for Simultaneous Quantification of the First-Line Anti-Tuberculosis Drugs and Six Primary Metabolites in Patient Plasma: Implications for Therapeutic Drug Monitoring Agnija Kivrane, Solveiga Grinberga, Eduards Sevostjanovs, Viktorija Igumnova, Ilva Pole, Anda Viksna, Dace Bandere, Alvils Krams, Andra Cirule, Osvalds Pugovics, Renate Ranka Journal of Chromatography B November 15, 2021 Tuberculosis (TB) is an infection caused by an airborne bacteria called Mycobacterium tuberculosis. Despite the advances in treating TB over the years there is still an estimated 10 million new cases around the...

Innovative Grade US Origin Rat Sprague Dawley Plasma and Pooled Human Plasma (Blood Derived) from Innovative Research were used in the following study:   Oligo(Lactic Acid)8-Docetaxel Prodrug-Loaded PEG-b-PLA Micelles for Prostate Cancer Lauren Repp, Christopher J. Unterberger, Zhengqing Ye, John B. Feltenberger, Steven M. Swanson, Paul C. Marker and Glen S. Kwon Nanomaterials October 17, 2021 Despite the progress medical science has made over the years in the field of cancer treatment, chemotherapy remains to be one of the most common methods used to combat cancer. An issue that various anticancer drug classes still face, however, is that many of...

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells Senquan Liu, Mengyao Wu, Moira Lancelot, Jiusheng Deng, Yongxing Gao, John D. Roback, Tong Chen, and Linzhao Cheng Molecular Therapy May 5, 2021 One of the most common treatments for patients with anemia or suffering from major blood loss is a red blood cell (RBC) transfusion from an ABO-matched donor. However, the number of cases that require these transfusions is increasing yearly, creating a growing need for blood donations amid blood shortages...

Pooled Human Plasma Apheresis Derived from Innovative Research was used in the following study:   Photooxidation-Induced Fluorescence Amplification System for an Ultra-Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Youhee Heo, Kwanwoo Shin, Min Cheol Park, and Ji Yoon Kang Scientific Reports March 12, 2021 It’s important to be able to detect biomarkers, such as proteins or nucleic acids, at very low concentrations in various bodily fluids when attempting to diagnose diseases. There has been a lot of contemporary research looking to identify other disease biomarkers, particularly ones detectable in blood, and reliable methods for detecting said biomarkers with low cost and high...

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer Eiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, Daisuke Saigusa, Bin Li, Kei Kudo, Keita Tsuji, Shogo Shigeta, Hideki Tokunaga, Kazuki Kumada, Keigo Komine, Hidekazu Shirota, Yuichi Aoki, Ikuko N. Motoike, Jun Yasuda, Kengo Kinoshita, Masayuki Yamamoto, Seizo Koshiba, and Nobuo Yaegashi Toxins June 30, 2021 Epithelial ovarian cancer (EOC) is a gynecological cancer with a high mortality rate, with a 5-year survival rate below 50%. Standard treatment for advanced EOC includes a combination...